VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BLLN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BLLNBillionToOne, Inc.
$97.50$4.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBLLNFinancials

BillionToOne, Inc. (BLLN) Income Statement

3Y historyFree accessUpdated daily

Revenue scaled to $123.0M with gross margin of 70.9% and operating margin expanding to 9.0% from -32.9% a year earlier, though SG&A at roughly 45% of revenue suggests operating leverage is still only partly developed.

Income StatementBalance SheetCash FlowRatios

BLLN Income Statement

Annual statement

BLLN Income Statement

BillionToOne, Inc. (BLLN) annual income statement — 3-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23
Sales/Revenue436.87M305.11M152.58M71.73M
Revenue Growth %71.9%99.97%112.72%-
Cost of Goods Sold124.92M96.65M71.67M54.42M
COGS % of Revenue-31.68%46.97%75.87%
Gross Profit311.95M208.46M80.92M17.31M
Gross Margin %71.41%68.32%53.03%24.13%
Gross Profit Growth %-157.63%367.5%-
Operating Expenses267.26M192.44M128.06M86.8M
OpEx % of Revenue-63.07%83.93%121.02%
Selling, General & Admin200.79M143.05M91.47M64.39M
SG&A % of Revenue-46.88%59.94%89.77%
Research & Development66.47M49.38M36.6M22.41M
R&D % of Revenue-16.19%23.98%31.25%
Other Operating Expenses0000
Operating Income44.69M16.02M-47.15M-69.5M
Operating Margin %10.23%5.25%-30.9%-96.89%
Operating Income Growth %-133.99%32.16%-
EBITDA60.41M27.93M-35.46M-63.03M
EBITDA Margin %13.83%9.15%-23.24%-87.88%
EBITDA Growth %916.88%178.77%43.75%-
D&A (Non-Cash Add-back)9.35M11.91M11.69M6.46M
EBIT49.74M7.85M-39.16M-79.4M
Net Interest Income17.48M7.66M3.43M184K
Interest Income17.51M7.75M5.82M3.46M
Interest Expense27K95K2.39M3.27M
Other Income/Expense5.02M-8.26M5.61M-13.18M
Pretax Income49.72M7.76M-41.54M-82.67M
Pretax Margin %11.38%2.54%-27.23%-115.26%
Income Tax324K305K29K9K
Effective Tax Rate %0.65%3.93%-0.07%-0.01%
Net Income49.39M7.45M-41.57M-82.68M
Net Margin %11.31%2.44%-27.24%-115.27%
Net Income Growth %447.73%117.93%49.72%-
Net Income (Continuing)49.39M7.45M-41.57M-82.68M
Discontinued Operations0000
Minority Interest0000
EPS (Diluted)0.920.14-4.12-1.85
EPS Growth %382.37%103.4%-122.7%-
EPS (Basic)-0.18-4.12-1.85
Diluted Shares Outstanding53.73M21.23M10.08M44.72M
Basic Shares Outstanding47.27M15.88M10.08M44.72M
Dividend Payout Ratio----

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Thin margins versus growth

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-Q (2026Q3)

Revenue Growth Re-Accelerated Through Latest Quarter

Based on the reported income statement, BLLN's quarterly revenue rose from $45.1M in 2024Q4 to $123.0M in 2026Q3, with year-over-year growth of 47.2% in the latest quarter after exceeding 110% in late 2025, suggesting the trajectory is decelerating from a low base but still strong.

The sequential climb across ten quarters indicates sustained commercial adoption rather than a single step change, though the year-over-year rate in 2026Q3 has compressed from the 113% to 117% range seen in late 2025. This compression is consistent with base-effect normalization and warrants monitoring of whether sequential dollar additions hold up as the comparison base grows larger. Investors should assess whether the growth remains volume-driven rather than reliant on pricing, since the reported figures do not separate these drivers.

Gross Margin Stable Near Seventy Percent

As reported in the income statement, BLLN's gross margin moved from 51.2% in 2024Q2 to 70.9% in 2026Q3, holding within a 70% to 73% band over the last five quarters and pointing to durable unit economics.

The recent stability of gross margin around 70% suggests the cost of revenue is scaling more slowly than sales, which is consistent with a diagnostic product whose incremental testing costs are relatively low. Peer comparison shows Illumina and CareDx at roughly 67% to 68% gross margin, placing BLLN in a comparable range rather than as a clear pricing-power outlier. The sustainability of this level depends on test mix and reimbursement dynamics, which the supplied data does not disclose.

Operating Leverage Emerging But Still Thin

Based on reported figures, BLLN's operating margin improved from negative 32.9% in 2024Q3 to 9.0% in 2026Q3, yet SG&A consumed about 45% of revenue in the latest quarter, indicating operating leverage is only partly developed.

Operating income has turned positive in recent quarters while SG&A has grown in absolute terms, which suggests the company is beginning to scale overhead more efficiently than gross profit. However, SG&A remains close to 45% of revenue, leaving limited room for error if growth decelerates. The next several quarters will show whether SG&A growth lags revenue growth enough to lift operating margin meaningfully above the current single-digit level.

Net Income Trails Operating Profit Consistently

According to reported financials, BLLN's latest net margin of 14.1% exceeded its operating margin of 9.0%, but earlier quarters show net income swinging sharply versus operating income, which warrants a closer look at non-operating items and tax effects.

The gap between operating and net income in recent quarters appears to reflect non-operating items or tax benefits rather than core operating performance, since net margin exceeded operating margin in 2026Q3. Stock-based compensation rose to $9.7M in the latest quarter, a meaningful share of operating income, which may be masking the underlying cash economics of the business. Investors should separate recurring operating earnings from one-time or non-cash items before extrapolating the latest EPS of $0.32.

Growth Durability and Margin Conversion Risks

The strongest bear case rests on BLLN's 2026Q3 operating margin of 9.0% against 47.2% revenue growth, as the spread between top-line expansion and bottom-line conversion may not persist if growth moderates from its base effect.

A skeptic would argue that the EPS beat of $0.32 against a $0.31 consensus is narrow and does not yet establish an earnings inflection, particularly with ROE near 2.3% in the supplied context. If revenue growth decelerates toward the peer range while SG&A stays near 45% of sales, operating margin could stall well below the level implied by the growth trajectory. Investors should treat the raised guidance tone as directional rather than quantified, given that no explicit forward targets are disclosed in the supplied data.

BLLN — Frequently Asked Questions

Quick answers to the most common questions about buying BLLN stock.

What was BillionToOne, Inc.'s (BLLN) revenue in 2025?

For fiscal year 2025, BillionToOne, Inc. (BLLN) reported total revenue of $305.1M. This represents a 325.4% increase compared to $71.7M in 2023.

Is BillionToOne, Inc. (BLLN) profitable?

BillionToOne, Inc. (BLLN) is profitable, generating $7.5M in net income for the fiscal year ending 2025 with a net profit margin of 2.4%.

What is BillionToOne, Inc.'s operating profit margin?

BillionToOne, Inc. (BLLN) reported an operating income of $16.0M, resulting in an operating profit margin of 5.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is BillionToOne, Inc.'s gross profit and gross margin?

BillionToOne, Inc. (BLLN) generated $208.5M in gross profit for the year, representing a gross profit margin of 68.3%. This demonstrates the company's core pricing power and production efficiency.